These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1478305)

  • 1. Blue versus white stimuli in ocular hypertension with the Friedmann Mark 1 Visual Field Analyser.
    Hugkulstone CE; Vernon SA
    Eye (Lond); 1992; 6 ( Pt 4)():356-60. PubMed ID: 1478305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a blue filter in visual field analysis.
    Hugkulstone CE; Vernon SA
    Br J Ophthalmol; 1991 Mar; 75(3):155-7. PubMed ID: 2012781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The groningen longitudinal glaucoma study III. The predictive value of frequency-doubling perimetry and GDx nerve fibre analyser test results for the development of glaucomatous visual field loss.
    Heeg GP; Jansonius NM
    Eye (Lond); 2009 Aug; 23(8):1647-52. PubMed ID: 19011607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with ocular hypertension have abnormal point scotopic thresholds in the superior hemifield.
    Stirling RJ; Pawson P; Brimlow GM; Vernon SA
    Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1608-17. PubMed ID: 8675404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blue-on-yellow visual field and retinal nerve fiber layer in ocular hypertension and glaucoma.
    Teesalu P; Airaksinen PJ; Tuulonen A
    Ophthalmology; 1998 Nov; 105(11):2077-81. PubMed ID: 9818609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual function-specific perimetry for indirect comparison of different ganglion cell populations in glaucoma.
    Sample PA; Bosworth CF; Blumenthal EZ; Girkin C; Weinreb RN
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1783-90. PubMed ID: 10845599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeatability of the Glaucoma Hemifield Test in automated perimetry.
    Katz J; Quigley HA; Sommer A
    Invest Ophthalmol Vis Sci; 1995 Jul; 36(8):1658-64. PubMed ID: 7601645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the OKP visual field screening test with the Humphrey field analyser.
    Vernon SA; Quigley HA
    Eye (Lond); 1992; 6 ( Pt 5)():521-4. PubMed ID: 1286719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Increased threshold for detection of phase differences in pattern-induced color flicker fusion in patients with glaucoma].
    Tritsch MF; Pfeiffer N
    Klin Monbl Augenheilkd; 1994 Jul; 205(1):27-32. PubMed ID: 7933905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The working threshold approach to Friedmann visual field analyser screening.
    Gutteridge IF
    Ophthalmic Physiol Opt; 1983; 3(1):41-6. PubMed ID: 6866521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Distribution of retinal sensitivity with blue on yellow perimetry in ocular hypertension].
    Maeda H; Tanaka Y; Sugiura T; Nakamura M; Yamamoto M
    Nippon Ganka Gakkai Zasshi; 1998 Feb; 102(2):111-6. PubMed ID: 9513357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The statistical interpretation of blue-on-yellow visual field loss.
    Wild JM; Moss ID; Whitaker D; O'Neill EC
    Invest Ophthalmol Vis Sci; 1995 Jun; 36(7):1398-410. PubMed ID: 7775118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of the pattern electroretinogram in high-risk ocular hypertension.
    Pfeiffer N; Tillmon B; Bach M
    Invest Ophthalmol Vis Sci; 1993 Apr; 34(5):1710-5. PubMed ID: 8473110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual-field loss with optic nerve drusen and ocular hypertension: a case report.
    Spalding JM
    Optometry; 2002 Jan; 73(1):24-32. PubMed ID: 12363235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between Humphrey 30-2 SITA Standard Test, Matrix 30-2 threshold test, and Heidelberg retina tomograph in ocular hypertensive and glaucoma patients.
    Bozkurt B; Yilmaz PT; Irkec M
    J Glaucoma; 2008; 17(3):203-10. PubMed ID: 18414106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Foveal and non-foveal measures of short wavelength sensitive pathways in glaucoma and ocular hypertension.
    Heron G; Adams AJ; Husted R
    Ophthalmic Physiol Opt; 1987; 7(4):403-4. PubMed ID: 3454916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing multifocal VEP and standard automated perimetry in high-risk ocular hypertension and early glaucoma.
    Fortune B; Demirel S; Zhang X; Hood DC; Patterson E; Jamil A; Mansberger SL; Cioffi GA; Johnson CA
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1173-80. PubMed ID: 17325161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual field damage proximal to fixation in normal- and high-tension glaucoma eyes.
    Koseki N; Araie M; Suzuki Y; Yamagami J
    Jpn J Ophthalmol; 1995; 39(3):274-83. PubMed ID: 8577079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting visual field loss in ocular hypertensive patients using wavelet-fourier analysis of GDx scanning laser polarimetry.
    Essock EA; Gunvant P; Zheng Y; Garway-Heath DF; Kotecha A; Spratt A
    Optom Vis Sci; 2007 May; 84(5):380-7. PubMed ID: 17502818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glaucomatous optic neuropathy causes sensitivity loss to light offsets in the visual field.
    Mutlukan E
    Neuroreport; 1993 Sep; 4(10):1159-62. PubMed ID: 8219010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.